论文部分内容阅读
医药行业是一个科技含量,集约化,国际化程度很高的产业,也是一个高投入,高收益的产业.随着改革开放的不断深入和外贸医药公司的大量涌入,加之中国已经加入WTO,中国医药行业正面临着巨大的冲击和挑战,尤其是医药分销行业.因为不管是医药批发还是医药零售,在加入WTO之前的保护性程度比较大,所以是开放后受影响比较大的行业之一。在此背景下,如何选择性的借鉴和运用发达国家的现代分销管理理论和经验,结合中国医药市场的实际现状,采用更为科学的分销与管理策略,是目前我国医药分销行业待研究和解决的课题。
The pharmaceutical industry is an industry with high scientific and technological content, intensification, and high degree of internationalization. It is also a high-input, high-yield industry. With the continuous deepening of reform and opening up and the influx of foreign trade pharmaceutical companies, plus China has joined the WTO, The Chinese pharmaceutical industry is facing tremendous challenges and challenges, especially in the pharmaceutical distribution industry. Because no matter whether it is pharmaceutical wholesale or pharmaceutical retail, the degree of protection before the accession to the WTO is relatively large, so it is one of the industries that will be affected more after opening up. . Under this background, how to selectively use and apply the modern distribution management theory and experience of developed countries, combined with the actual status quo of China’s pharmaceutical market, adopt more scientific distribution and management strategies, is currently China’s pharmaceutical distribution industry to be studied and resolved. Subject.